CLDXCelldex Therapeutics

$2.63
$-0.08 (-3%)

Celldex Therapeutics (CLDX) Stock Analysis

Create a FREE Account to View Full CLDX Stock Report

Celldex Therapeutics (CLDX) Analyst Forecast

Next 12 months ➝Current Price$2.6352-week High$5.5652-week Low$2.01MEAN$13.50+413.31%HIGH$19.00+622.43%LOW$8.00+204.18%
  • Last Price$2.63
  • Previous Close$2.71
  • Change $-0.08
  • Open$2.63
  • Volume272,164
  • Avg. Volume (100-day)238,664
  • Market Capitalization$43.96M
  • Days Range $2.56 - $2.75
  • 52-week Range $2.01 - $5.56
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-3.35
  • Earnings Date03/05/2020
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta-0.115
  • PEG Ratio
  • Volatility0.79
  • Average True Range0.06
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.